Ad is loading...
BGLAF
Price
$10.50
Change
-$0.00 (-0.00%)
Updated
Oct 1 closing price
SNOA
Price
$2.56
Change
-$0.02 (-0.78%)
Updated
Nov 15 closing price
Ad is loading...

BGLAF vs SNOA

Header iconBGLAF vs SNOA Comparison
Open Charts BGLAF vs SNOABanner chart's image
Biogaia AB
Price$10.50
Change-$0.00 (-0.00%)
Volume$375
CapitalizationN/A
Sonoma Pharmaceuticals
Price$2.56
Change-$0.02 (-0.78%)
Volume$15.31K
CapitalizationN/A
BGLAF vs SNOA Comparison Chart
Loading...
SNOA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BGLAF vs. SNOA commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGLAF is a Hold and SNOA is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BGLAF: $10.50 vs. SNOA: $2.56)
Brand notoriety: BGLAF and SNOA are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BGLAF: 109% vs. SNOA: 7%
Market capitalization -- BGLAF: $1B vs. SNOA: $2.39M
BGLAF [@Pharmaceuticals: Other] is valued at $1B. SNOA’s [@Pharmaceuticals: Other] market capitalization is $2.39M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BGLAF’s FA Score shows that 2 FA rating(s) are green whileSNOA’s FA Score has 0 green FA rating(s).

  • BGLAF’s FA Score: 2 green, 3 red.
  • SNOA’s FA Score: 0 green, 5 red.
According to our system of comparison, BGLAF is a better buy in the long-term than SNOA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNOA’s TA Score shows that 2 TA indicator(s) are bullish.

  • SNOA’s TA Score: 2 bullish, 6 bearish.

Price Growth

BGLAF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while SNOA (@Pharmaceuticals: Other) price change was -8.57% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Reported Earning Dates

SNOA is expected to report earnings on Nov 08, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BGLAF($1B) has a higher market cap than SNOA($2.39M). BGLAF YTD gains are higher at: 5.422 vs. SNOA (-29.044). BGLAF has higher annual earnings (EBITDA): 529M vs. SNOA (-4.27M). BGLAF has more cash in the bank: 1.37B vs. SNOA (2.41M). BGLAF has higher revenues than SNOA: BGLAF (1.21B) vs SNOA (12.3M).
BGLAFSNOABGLAF / SNOA
Capitalization1B2.39M41,865%
EBITDA529M-4.27M-12,389%
Gain YTD5.422-29.044-19%
P/E Ratio25.58N/A-
Revenue1.21B12.3M9,862%
Total Cash1.37B2.41M56,941%
Total DebtN/A385K-
FUNDAMENTALS RATINGS
SNOA: Fundamental Ratings
SNOA
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
71
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SNOA
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
SNOA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SILC14.390.39
+2.79%
Silicom Ltd
SONN3.020.02
+0.67%
Sonnet BioTherapeutics Holdings Inc
SXI202.270.06
+0.03%
Standex International Corp
KNX55.63-0.28
-0.50%
Knight-Swift Transportation Holdings
CRVS8.19-0.33
-3.87%
Corvus Pharmaceuticals

BGLAF and

Correlation & Price change

A.I.dvisor tells us that BGLAF and SNOA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BGLAF and SNOA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGLAF
1D Price
Change %
BGLAF100%
N/A
SNOA - BGLAF
30%
Poorly correlated
-0.77%
CTTH - BGLAF
28%
Poorly correlated
-8.57%
CRYM - BGLAF
22%
Poorly correlated
-2.04%
SHPH - BGLAF
8%
Poorly correlated
-6.82%
DHBUF - BGLAF
5%
Poorly correlated
+5.41%
More

SNOA and

Correlation & Price change

A.I.dvisor tells us that SNOA and BNXTF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNOA and BNXTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNOA
1D Price
Change %
SNOA100%
-0.77%
BNXTF - SNOA
29%
Poorly correlated
+3.63%
BGLAF - SNOA
27%
Poorly correlated
N/A
OGI - SNOA
25%
Poorly correlated
-4.00%
AKAN - SNOA
25%
Poorly correlated
-6.08%
TAK - SNOA
23%
Poorly correlated
+0.37%
More